NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Just Updated: Compare Your Institution (Live Data)
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025 (Updated Today)
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
For Students
local_fire_department
Country Reports
person
Find a Professional
Lisa Bodei
Memorial Sloan Kettering Cancer Center - Indore / United States
Medical and Health Sciences / Nuclear Medicine
AD Scientific Index ID: 4441141
Registration, Add Profile,
Premium Membership
Get Your Global Impact Certificate
Ranking &
Analysis
Job
Experiences
Education
Information
Published Books
Book Chapters
Articles
Presentations
Lessons
Projects
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board
Patents /
Designs
Academic Grants
& Awards
Artistic
Activities
Certificate / Course
/ Trainings
Association &
Society Memberships
Contact, Office
& Social Media
person_outline
Lisa Bodei's MOST POPULAR ARTICLES
1-)
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours European journal of nuclear medicine and molecular imaging 40, 800-816, 2013
2-)
Radiopharmaceutical therapy in cancer: clinical advances and challenges Nature reviews Drug discovery 19 (9), 589-608, 2020
3-)
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs Journal of Nuclear Medicine 46 (1 suppl), 62S-66S, 2005
4-)
Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study European journal of nuclear medicine and molecular imaging 38, 2125-2135, 2011
5-)
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors European journal of nuclear medicine and molecular imaging 35, 1847-1856, 2008
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept